LOVELAND, Colo., Nov. 2, 2011 /PRNewswire/ -- Heska Corporation
(NASDAQ: HSKA), a provider of advanced veterinary diagnostic and
other specialty veterinary products, today announced that
Robert Grieve, Heska's Chairman and
CEO, will present at the 7th Annual Fall Growth Stock Conference
hosted by Security Research Associates, Inc. ("SRA"). The
conference will be held on Tuesday, November
15, at the Le Meridien Hotel in San Francisco.
Conference attendees will include a select group of
institutional portfolio managers and analysts, and will feature
CEOs and CFOs from some of the fastest growing companies in the
technology and life sciences sectors. SRA has arranged for
webcasting of company presentations during this event. To access
the lobby page for the webcast of presenting companies please go
to: http://www.videonewswire.com/event.asp?id=82625.
Dr. Grieve commented, "We look forward to articulating Heska's
opportunity to the professional investment community. We have a
strong base of recurring revenue, more than $1 per share in cash and no debt. In addition,
our commercial network is expanding, targeting a large market
opportunity with favorable demographics."
About Security Research Associates, Inc.
SRA was founded in San
Francisco in 1980 and, today, offers investment banking and
M&A services as well as institutional brokerage services. A
boutique firm by design, SRA works with a select group of portfolio
managers from around the country and focuses on technology and life
science companies in the micro and small cap arenas. For more
information about SRA see our web site at www.sracap.com or call us
at 415-925-0346.
About Heska
Heska Corporation (NASDAQ: HSKA) sells advanced veterinary
diagnostic and other specialty veterinary products. Heska's
state-of-the-art offerings to its customers include diagnostic
instruments and supplies as well as single use, point-of-care
tests, pharmaceuticals and vaccines. The company's core focus is on
the canine and feline markets where it strives to provide high
value products and unparalleled customer support to veterinarians.
For further information on Heska and its products, visit the
company's website at www.heska.com.
Forward-Looking Statements
This announcement contains forward-looking statements
regarding Heska's future financial and operating results. For
example, Dr. Grieve's stated expectations for new product launches
are forward-looking. These statements are based on current
expectations and are subject to a number of risks and
uncertainties. Investors should note that there is an inherent risk
in using past results, including trends, to predict future
outcomes. In addition, factors that could affect the business
and financial results of Heska generally include the following:
risks related to Heska's reliance on third parties to develop
certain of Heska's future products; risks related to Heska's
ability to increase the productivity of its sales force; risks
related to the implementation of current product development plans,
including anticipated launch dates; risks regarding Heska's
reliance on third-party suppliers such as minimum purchase
requirements, which could have a significant adverse impact on
Heska's financial position; uncertainties related to Heska's
ability to hire and retain effective individuals to fill currently
vacant positions; uncertainties related to Heska's ability to
successfully commercialize new products; uncertainties regarding
Heska's reliance on third parties to whom Heska has granted
substantial marketing rights to certain of Heska's existing
products and who may be large Heska customers, including
Schering-Plough Animal Health Corporation which has exclusive
rights to Heska's heartworm preventive in the United States; uncertainties regarding
Heska's ability to successfully market and sell its products in an
economically sustainable manner; competition; risks related to
Heska's ability to generate levels of profitability to utilize
significantly its deferred tax assets; and the risks set forth in
Heska's filings and future filings with the Securities and Exchange
Commission, including those set forth in Heska's Quarterly Report
on Form 10-Q for the quarter ended June 30,
2011.
SOURCE Heska Corporation